Content uniformity is one of the most important release criteria for solid dosage forms. In pharmaceutical continuous manufacturing (PCM), what process analytical technologies (PAT) are available to measure and assure content uniformity as part of a real-time release (RTR) strategy?

In a new article in Pharmaceutical Online, titled “Pharmaceutical Continuous Manufacturing: Content Uniformity with PAT & RTR,” Richard Steiner of Pharmatech Associates tackles that question and more. His paper discusses PCM solutions and best practices to ensure content uniformity, applying Quality by Design (QbD) principles to achieve real-time release testing — creating an opportunity for drug sponsors to simplify processes and reduce costs.

Click here to read the full article